Kuehne+Nagel partners with Chinese pharma specialist

February 26, 2021

Alliance with Jointown comes in time for Covid-19 vaccine storage and distribution efforts

Kuehne+Nagel, a third-party logistics (3PL) provider, has struck a strategic partnership with Jointown, China’s largest non-state-owned pharma distribution company, to accelerate its footprint in pharma and healthcare logistics in China.

Over the past decade, Kuehne+Nagel has been focused on developing pharma and healthcare expertise. The partnership with Jointown provides access to the distributor’s fully GxP (good practice)-compliant, in-country storage and distribution network, enabling Kuehne+Nagel to comply with the highly-regulated Chinese pharma and healthcare sector.

With Covid-19 vaccines becoming widely approved for use, Jointown and Kuehne+Nagel will collaborate to manage vaccine distribution in a safe and timely manner, executives say, using their respective strengths in vaccine storage and distribution, both in China and other regions

The Jointown agreement comes only a few days after Kuehne+Nagel entered into a binding agreement to purchase Apex International Corporation, one of Asia’s leading freight forwarders, in its largest acquisition to date.